These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27429855)

  • 1. Elevated ASCL2 expression is associated with metastasis of osteosarcoma and predicts poor prognosis of the patients.
    Liu MH; Cui YH; Guo QN; Zhou Y
    Am J Cancer Res; 2016; 6(6):1431-40. PubMed ID: 27429855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated expression of ASCL2 is an independent prognostic indicator in lung squamous cell carcinoma.
    Hu XG; Chen L; Wang QL; Zhao XL; Tan J; Cui YH; Liu XD; Zhang X; Bian XW
    J Clin Pathol; 2016 Apr; 69(4):313-8. PubMed ID: 26483561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of Semaphorin-3F is associated with poor prognostic significance in osteosarcoma patients.
    Liu MH; Fu WJ; Cui YH; Guo QN; Zhou Y
    Am J Cancer Res; 2016; 6(10):2252-2262. PubMed ID: 27822415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated ASCL2 expression in breast cancer is associated with the poor prognosis of patients.
    Xu H; Zhao XL; Liu X; Hu XG; Fu WJ; Li Q; Wang Y; Ping YF; Zhang X; Bian XW; Yao XH
    Am J Cancer Res; 2017; 7(4):955-961. PubMed ID: 28469967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLA2G16 Expression in Human Osteosarcoma Is Associated with Pulmonary Metastasis and Poor Prognosis.
    Liang S; Ren Z; Han X; Yang J; Shan L; Li L; Wang B; Zhang Q; Mu T; Chen K; Xiong S; Wang G
    PLoS One; 2015; 10(5):e0127236. PubMed ID: 25993412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASCL2 expression contributes to gastric tumor migration and invasion by downregulating miR223 and inducing EMT.
    Zuo Q; Wang J; Chen C; Zhang Y; Feng DX; Zhao R; Chen T
    Mol Med Rep; 2018 Oct; 18(4):3751-3759. PubMed ID: 30106147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma.
    Thanapprapasr K; Nartthanarung A; Thanapprapasr D; Jinawath A
    PLoS One; 2017; 12(8):e0182989. PubMed ID: 28846700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated expression of AKT2 correlates with disease severity and poor prognosis in human osteosarcoma.
    Zhu Y; Zhou J; Ji Y; Yu B
    Mol Med Rep; 2014 Aug; 10(2):737-42. PubMed ID: 24919955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of relaxin-2 and S100A4 expression in osteosarcoma.
    Huang H; Zheng HY; Liu ZL; Zhang L
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2828-34. PubMed ID: 25339476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SEMA3F prevents metastasis of colorectal cancer by PI3K-AKT-dependent down-regulation of the ASCL2-CXCR4 axis.
    Zhou ZH; Rao J; Yang J; Wu F; Tan J; Xu SL; Ding Y; Zhan N; Hu XG; Cui YH; Zhang X; Dong W; Liu XD; Bian XW
    J Pathol; 2015 Aug; 236(4):467-78. PubMed ID: 25866254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and prognostic relevance of centromere protein A in primary osteosarcoma.
    Gu XM; Fu J; Feng XJ; Huang X; Wang SM; Chen XF; Zhu MH; Zhang SH
    Pathol Res Pract; 2014 Apr; 210(4):228-33. PubMed ID: 24440098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined over-expression of the hypoxia-inducible factor 2α gene and its long non-coding RNA predicts unfavorable prognosis of patients with osteosarcoma.
    Li W; He X; Xue R; Zhang Y; Zhang X; Lu J; Zhang Z; Xue L
    Pathol Res Pract; 2016 Oct; 212(10):861-866. PubMed ID: 27623205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic significance of S100A4 expression in osteosarcoma.
    Cao CM; Yang FX; Wang PL; Yang QX; Sun XR
    Eur Rev Med Pharmacol Sci; 2014; 18(6):833-9. PubMed ID: 24706307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-21 predicts poor prognosis in patients with osteosarcoma.
    Ren X; Shen Y; Zheng S; Liu J; Jiang X
    Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal Stem Cell Marker ASCL2 is a Novel Prognostic Predictor in Esophageal Adenocarcinoma.
    Shibahara Y; Espin-Garcia O; Conner J; Weiss J; Derouet M; Allen J; Allison F; Kalimuthu S; Yeung JC; Darling GE
    Cureus; 2022 Jan; 14(1):e21021. PubMed ID: 35154991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Significance of G Protein-Coupled Receptor 110 (GPR110) as a Novel Prognostic Biomarker in Osteosarcoma.
    Liu Z; Zhang G; Zhao C; Li J
    Med Sci Monit; 2018 Jul; 24():5216-5224. PubMed ID: 30052620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of STAT5A predicts poor prognosis in osteosarcoma.
    Guo Z; Tang Y; Fu Y; Wang J
    Pathol Res Pract; 2019 Mar; 215(3):519-524. PubMed ID: 30638860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological and prognostic values of fibronectin and integrin αvβ3 expression in primary osteosarcoma.
    Shi K; Wang SL; Shen B; Yu FQ; Weng DF; Lin JH
    World J Surg Oncol; 2019 Jan; 17(1):23. PubMed ID: 30691475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Immunohistochemical Study of Stathmin 1 Expression in Osteosarcoma Shows an Association with Metastases and Poor Patient Prognosis.
    Zhao C; Li H; Wang L; Sun W
    Med Sci Monit; 2018 Aug; 24():6070-6078. PubMed ID: 30169496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bufalin inhibits gastric cancer invasion and metastasis by down-regulating Wnt/ASCL2 expression.
    Wang J; Cai H; Xia Y; Wang S; Xing L; Chen C; Zhang Y; Xu J; Yin P; Jiang Y; Zhao R; Zuo Q; Chen T
    Oncotarget; 2018 May; 9(34):23320-23333. PubMed ID: 29805736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.